261 related articles for article (PubMed ID: 10213216)
1. O6-methylguanine-DNA methyltransferase-deficient phenotype in human gliomas: frequency and time to tumor progression after alkylating agent-based chemotherapy.
Silber JR; Blank A; Bobola MS; Ghatan S; Kolstoe DD; Berger MS
Clin Cancer Res; 1999 Apr; 5(4):807-14. PubMed ID: 10213216
[TBL] [Abstract][Full Text] [Related]
2. O6-methylguanine-DNA methyltransferase activity in adult gliomas: relation to patient and tumor characteristics.
Silber JR; Bobola MS; Ghatan S; Blank A; Kolstoe DD; Berger MS
Cancer Res; 1998 Mar; 58(5):1068-73. PubMed ID: 9500473
[TBL] [Abstract][Full Text] [Related]
3. O6-Methylguanine-DNA methyltransferase in pediatric primary brain tumors: relation to patient and tumor characteristics.
Bobola MS; Berger MS; Ellenbogen RG; Roberts TS; Geyer JR; Silber JR
Clin Cancer Res; 2001 Mar; 7(3):613-9. PubMed ID: 11297257
[TBL] [Abstract][Full Text] [Related]
4. O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort.
Pollack IF; Hamilton RL; Sobol RW; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL
J Clin Oncol; 2006 Jul; 24(21):3431-7. PubMed ID: 16849758
[TBL] [Abstract][Full Text] [Related]
5. Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents.
Kokkinakis DM; Ahmed MM; Delgado R; Fruitwala MM; Mohiuddin M; Albores-Saavedra J
Cancer Res; 1997 Dec; 57(23):5360-8. PubMed ID: 9393761
[TBL] [Abstract][Full Text] [Related]
6. Tetrazepinones are equally cytotoxic to Mer+ and Mer- human tumor cell lines.
Jean-Claude BJ; Mustafa A; Watson AJ; Damian Z; Vasilescu D; Chan TH; Leyland-Jones B
J Pharmacol Exp Ther; 1999 Feb; 288(2):484-9. PubMed ID: 9918549
[TBL] [Abstract][Full Text] [Related]
7. Careful exclusion of non-neoplastic brain components is required for an appropriate evaluation of O6-methylguanine-DNA methyltransferase status in glioma: relationship between immunohistochemistry and methylation analysis.
Sasai K; Nodagashira M; Nishihara H; Aoyanagi E; Wang L; Katoh M; Murata J; Ozaki Y; Ito T; Fujimoto S; Kaneko S; Nagashima K; Tanaka S
Am J Surg Pathol; 2008 Aug; 32(8):1220-7. PubMed ID: 18580490
[TBL] [Abstract][Full Text] [Related]
8. Comparison of O6-methylguanine-DNA methyltransferase activity in brain tumors and adjacent normal brain.
Silber JR; Mueller BA; Ewers TG; Berger MS
Cancer Res; 1993 Jul; 53(14):3416-20. PubMed ID: 8324751
[TBL] [Abstract][Full Text] [Related]
9. Relationship between O6-methylguanine-DNA methyltransferase levels and clinical response induced by chloroethylnitrosourea therapy in glioma patients.
Chen ZP; Yarosh D; Garcia Y; Tampieri D; Mohr G; Malapetsa A; Langleben A; Panasci LC
Can J Neurol Sci; 1999 May; 26(2):104-9. PubMed ID: 10352868
[TBL] [Abstract][Full Text] [Related]
10. Apurinic endonuclease activity in adult gliomas and time to tumor progression after alkylating agent-based chemotherapy and after radiotherapy.
Bobola MS; Emond MJ; Blank A; Meade EH; Kolstoe DD; Berger MS; Rostomily RC; Silbergeld DL; Spence AM; Silber JR
Clin Cancer Res; 2004 Dec; 10(23):7875-83. PubMed ID: 15585620
[TBL] [Abstract][Full Text] [Related]
11. Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity.
Vassal G; Boland I; Terrier-Lacombe MJ; Watson AJ; Margison GP; Vénuat AM; Morizet J; Parker F; Lacroix C; Lellouch-Tubiana A; Pierre-Kahn A; Poullain MG; Gouyette A
Clin Cancer Res; 1998 Feb; 4(2):463-8. PubMed ID: 9516937
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
Metellus P; Coulibaly B; Nanni I; Fina F; Eudes N; Giorgi R; Barrie M; Chinot O; Fuentes S; Dufour H; Ouafik L; Figarella-Branger D
Cancer; 2009 Oct; 115(20):4783-94. PubMed ID: 19637364
[TBL] [Abstract][Full Text] [Related]
13. Human glioma cell sensitivity to the sequence-specific alkylating agent methyl-lexitropsin.
Bobola MS; Varadarajan S; Smith NW; Goff RD; Kolstoe DD; Blank A; Gold B; Silber JR
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):612-20. PubMed ID: 17255284
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas.
Brell M; Tortosa A; Verger E; Gil JM; Viñolas N; Villá S; Acebes JJ; Caral L; Pujol T; Ferrer I; Ribalta T; Graus F
Clin Cancer Res; 2005 Jul; 11(14):5167-74. PubMed ID: 16033832
[TBL] [Abstract][Full Text] [Related]
15. Cytosine methylation and suppression of O6-methylguanine-DNA methyltransferase expression in human rhabdomyosarcoma cell lines and xenografts.
von Wronski MA; Harris LC; Tano K; Mitra S; Bigner DD; Brent TP
Oncol Res; 1992; 4(4-5):167-74. PubMed ID: 1504376
[TBL] [Abstract][Full Text] [Related]
16. O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines.
Bobola MS; Silber JR; Ellenbogen RG; Geyer JR; Blank A; Goff RD
Clin Cancer Res; 2005 Apr; 11(7):2747-55. PubMed ID: 15814657
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of O6-methylguanine-DNA methyltransferase gene expression in gliomas by platinum compounds.
Tanaka S; Kobayashi I; Utsuki S; Oka H; Yasui Y; Fujii K
Oncol Rep; 2005 Nov; 14(5):1275-80. PubMed ID: 16211296
[TBL] [Abstract][Full Text] [Related]
18. Enforced expression of wild-type p53 curtails the transcription of the O(6)-methylguanine-DNA methyltransferase gene in human tumor cells and enhances their sensitivity to alkylating agents.
Srivenugopal KS; Shou J; Mullapudi SR; Lang FF; Rao JS; Ali-Osman F
Clin Cancer Res; 2001 May; 7(5):1398-409. PubMed ID: 11350911
[TBL] [Abstract][Full Text] [Related]
19. Activity of the DNA repair protein O6-methylguanine-DNA methyltransferase in human tumor and corresponding normal tissue.
Preuss I; Haas S; Eichhorn U; Eberhagen I; Kaufmann M; Beck T; Eibl RH; Dall P; Bauknecht T; Hengstler J; Wittig BM; Dippold W; Kaina B
Cancer Detect Prev; 1996; 20(2):130-6. PubMed ID: 8706038
[TBL] [Abstract][Full Text] [Related]
20. Contribution of O6-methylguanine-DNA methyltransferase to monofunctional alkylating-agent resistance in human brain tumor-derived cell lines.
Bobola MS; Blank A; Berger MS; Silber JR
Mol Carcinog; 1995 Jun; 13(2):70-80. PubMed ID: 7605582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
